4 results
Approved WMOCompleted
Primary: to compare the efficacy and safety of once daily (evening) administration of FF/VI 100/25 with FF 100 in adult and adolescent subjects >= 12 years of age with moderate to severe, persistent bronchial asthma over 12 weeks.Secondary:…
Approved WMOCompleted
Efficacy and safety during 24 treatment weeks.
Approved WMOCompleted
The primary objective of this study is to evaluate if PVI performed with cryoballoon and other cryocatheters is superior to AAD as first-line therapy in preventing atrial arrhythmia recurrences
Approved WMOCompleted
Primary: Efficacy of FF/GW642444 100/25 mcg once daily in comparison with that of FP/salmeterol 250/50 mcg twice daily during 24 weeks.Secundary: Safety and tolerability.